Table 3. SNV analysis of multiple regions of the ovarian cancer in the patient with synchronous cancers.
Group of SNVsNo. of SNVs in tumorPresurgery plasmaPostsurgery plasma
No. of sequence reads showing SNVs in plasma (p)No. of sequence reads showing wild-type sequence in plasma (q)Deduced fractional concentration of tumor-derived DNA Embedded ImageNo. of sequence reads showing SNVs in plasma (p)No. of sequence reads showing wild-type sequence in plasma (q)Deduced fractional concentration of tumor-derived DNA Embedded Image
A713733212.2%521490.46%
B122856330.28%135160.06%
C1685185071.2%254380.07%
D2482610 8800.48%270600.06%
AB10214239.5%02970%
CD1235691.1%03330%
ABCD221621 34470 94046%5461 4170.18%